Bussemakers MJ - Search Results

1

Isolation and characterization of the promoter of the human prostate cancer-specific DD3 gene.

Verhaegh GW, van Bokhoven A, Smit F, Schalken JA, Bussemakers MJ. Verhaegh GW, et al. Among authors: bussemakers mj. J Biol Chem. 2000 Dec 1;275(48):37496-503. doi: 10.1074/jbc.M006293200. J Biol Chem. 2000. PMID: 10982808 Free article.

2

Oncogene expression in prostate cancer.

Schalken JA, Bussemakers MJ, Debruyne FM. Schalken JA, et al. Among authors: bussemakers mj. Prog Clin Biol Res. 1990;357:97-105. Prog Clin Biol Res. 1990. PMID: 2217484 Review.

3

Transcriptional regulation of the human E-cadherin gene in human prostate cancer cell lines: characterization of the human E-cadherin gene promoter.

Bussemakers MJ, Giroldi LA, van Bokhoven A, Schalken JA. Bussemakers MJ, et al. Biochem Biophys Res Commun. 1994 Sep 15;203(2):1284-90. doi: 10.1006/bbrc.1994.2321. Biochem Biophys Res Commun. 1994. PMID: 8093045

4

DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.

Bussemakers MJ, van Bokhoven A, Verhaegh GW, Smit FP, Karthaus HF, Schalken JA, Debruyne FM, Ru N, Isaacs WB. Bussemakers MJ, et al. Cancer Res. 1999 Dec 1;59(23):5975-9. Cancer Res. 1999. PMID: 10606244

5

Cadherin switching in human prostate cancer progression.

Tomita K, van Bokhoven A, van Leenders GJ, Ruijter ET, Jansen CF, Bussemakers MJ, Schalken JA. Tomita K, et al. Among authors: bussemakers mj. Cancer Res. 2000 Jul 1;60(13):3650-4. Cancer Res. 2000. PMID: 10910081

6

P-Cadherin is a basal cell-specific epithelial marker that is not expressed in prostate cancer.

Jarrard DF, Paul R, van Bokhoven A, Nguyen SH, Bova GS, Wheelock MJ, Johnson KR, Schalken J, Bussemakers M, Isaacs WB. Jarrard DF, et al. Among authors: bussemakers m. Clin Cancer Res. 1997 Nov;3(11):2121-8. Clin Cancer Res. 1997. PMID: 9815605

7

The prognostic value of E-cadherin and the cadherin-associated molecules alpha-, beta-, gamma-catenin and p120ctn in prostate cancer specific survival: a long-term follow-up study.

van Oort IM, Tomita K, van Bokhoven A, Bussemakers MJ, Kiemeney LA, Karthaus HF, Witjes JA, Schalken JA. van Oort IM, et al. Among authors: bussemakers mj. Prostate. 2007 Sep 15;67(13):1432-8. doi: 10.1002/pros.20626. Prostate. 2007. PMID: 17639504

8

Increased expression of retroviral sequences in progressionally advanced rat prostatic tumors.

Bussemakers MJ, van Bokhoven A, van Groningen JJ, Debruyne FM, Schalken JA. Bussemakers MJ, et al. Biochem Biophys Res Commun. 1992 Jan 15;182(1):318-24. doi: 10.1016/s0006-291x(05)80147-0. Biochem Biophys Res Commun. 1992. PMID: 1370615

9

Differential expression of vimentin in rat prostatic tumors.

Bussemakers MJ, Verhaegh GW, van Bokhoven A, Debruyne FM, Schalken JA. Bussemakers MJ, et al. Biochem Biophys Res Commun. 1992 Feb 14;182(3):1254-9. doi: 10.1016/0006-291x(92)91866-o. Biochem Biophys Res Commun. 1992. PMID: 1540169

10

Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis.

Bussemakers MJ, van de Ven WJ, Debruyne FM, Schalken JA. Bussemakers MJ, et al. Cancer Res. 1991 Jan 15;51(2):606-11. Cancer Res. 1991. PMID: 1702360

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters